Aspen is giving up on local lenacapavir production because demand isn’t guaranteed. Instead, the company is supporting Merck’s alimatravir pill as a means of preventing HIV. Aspen Pharmacare has walked away from government plans to produce lenacapavir locally. This is the clearest sign yet that South Africa’s bid to make its own HIV prevention injection faces stiff commercial headwinds. Instead,…
Tag: Alimatravir
-
Aspen HIV Prevention Pill Deal Expands African Access
Aspen Pharmacare will become a major African supplier of Merck’s experimental monthly HIV prevention pill, alimatravir. The agreement depends on the medicine successfully completing clinical trials and receiving regulatory approval. Merck granted voluntary licenses to seven generic drug manufacturers, including the South African company, to produce and distribute lower-cost versions of the medicine. The drug also goes by its development…